MedTrace Logo

PANDA-Regional Feasibility Study of a Smartphone Pain Management Application

NCT03369392 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2019-04-19

No results posted yet for this study

Summary

Despite the numerous benefits of peripheral nerve blocks (PNBs) over general anesthesia (GA) in a variety of surgical procedures, PNBs can be associated with increased post-operative pain if pain medications are not taken correctly (titrated). Unfortunately, this is a common occurrence as patients often have difficulty titrating medications in the absence of direct medical care. PANDA, a smartphone-based postoperative pain management tool, is designed to address this issue by helping patients manage their pain medications. The purpose of this study is to demonstrate the feasibility of this application in patients who are discharged after receiving PNBs. The goal is to identify areas of improvement for the application itself. It is hypothesize that PANDA will be successful in supporting patients' postoperative pain management.

Conditions

  • Postoperative Pain
  • Anesthesia, Conduction

Interventions

OTHER

Panda application

A smartphone-based postoperative pain management tool

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Ronald Ree, MD · University of British Columbia

  • Cynthia Fan, MD · University of British Columbia

  • Mark Ansermino, MBBCH · University of British Columbia

  • Terri Sun, MD · University of British Columbia

  • Lily Yu Long Chiu, MD · University of British Columbia

  • Dustin Dunsmuir · University of British Columbia

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
19 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-11
Primary Completion
2019-03-31
Completion
2019-03-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03369392 on ClinicalTrials.gov